NCE5: Decoding the Bone Threshold for Sinus Augmentation Success

Presenters

Description

The conventional 5mm residual bone height (RBH) threshold for transcrestal sinus augmentation is an obsolete concept challenged by modern evidence. Current research establishes that bone density, not height, is the primary determinant of implant stability. Different techniques, as osseodensification or under-drilling, enable predictable primary stability in RBH as low as 3-4mm, shifting the clinical focus from mechanical retention to biological success. The main challenge in low RBH cases is not stability, but achieving safe bone gain while managing the high, often undetected, risk of Schneiderian membrane perforation. A biological paradigm shift is proposed, leveraging the discovery of mesenchymal stem cells (MSCs) within the membrane itself. Applying Platelet-Rich Fibrin (PRF) can activate these cells, transforming the membrane from a passive barrier into an active partner in regeneration. Furthermore, PRF acts as a risk manager, as its dispersion through a perforation has no clinical consequence, unlike particulate grafts. This advanced approach is well-documented for single-implant sites. However, a significant gap exists in the literature regarding its application to multiple adjacent edentulous sites. Therefore, extrapolating these promising results to larger cases must be done with extreme caution, as this area remains a clinical frontier requiring further research.

---

Educational Objectives

• Assess the key factors for ensuring implant stability when residual bone height is less than 4 mm.
• Identify the risk factors for Schneiderian membrane perforation and learn how to manage these tears in conditions of limited bone height.
• Select practical and predictable methods for successfully performing this intervention.

---

CE Hours: 0.75

---